HER2 Type Male Breast Cancer Successfully Treated with Pertuzumab, Trastuzumab, and Eribulin Therapy: A Case Report

MLA

Satoshi Okazaki, et al. “HER2 Type Male Breast Cancer Successfully Treated with Pertuzumab, Trastuzumab, and Eribulin Therapy: A Case Report.” Journal of Cancer Therapy, vol. 11, Jan. 2020, pp. 154–59. EBSCOhost, https://doi.org/10.4236/jct.2020.113013.

APA

Satoshi Okazaki, Shunsuke Yasuda, Masahiro Abe, Nana Yoshida, Kei Ishibashi, & Masahiro Kitada. (2020). HER2 Type Male Breast Cancer Successfully Treated with Pertuzumab, Trastuzumab, and Eribulin Therapy: A Case Report. Journal of Cancer Therapy, 11, 154–159. https://doi.org/10.4236/jct.2020.113013

Chicago

Satoshi Okazaki, Shunsuke Yasuda, Masahiro Abe, Nana Yoshida, Kei Ishibashi, and Masahiro Kitada. 2020. “HER2 Type Male Breast Cancer Successfully Treated with Pertuzumab, Trastuzumab, and Eribulin Therapy: A Case Report.” Journal of Cancer Therapy 11 (January): 154–59. doi:10.4236/jct.2020.113013.